首页> 美国卫生研究院文献>Journal of Korean Medical Science >Clinical Characteristics of Renal Cell Carcinoma in Korean Patients with von Hippel-Lindau Disease Compared to Sporadic Bilateral or Multifocal Renal Cell Carcinoma
【2h】

Clinical Characteristics of Renal Cell Carcinoma in Korean Patients with von Hippel-Lindau Disease Compared to Sporadic Bilateral or Multifocal Renal Cell Carcinoma

机译:与偶发性双侧或多灶性肾细胞癌相比韩国von Hippel-Lindau病患者肾细胞癌的临床特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

This study was done to analyze the clinical characteristics of renal cell carcinoma (RCC) in Korean patients with von Hippel-Lindau (VHL) disease. Between January 1996 and July 2008, 1,514 patients were diagnosed with RCC and 24 patients were diagnosed with VHL disease at our institute. We analyzed the clinical characteristics of the 24 patients diagnosed with VHL. The mean age of patients with VHL was 39.2±12.6 yr; the mean age of patients with both VHL and RCC was 42.5±10.3 yr. Among the 24 patients with VHL, 7 patients had retinal angiomas, 11 had RCC, 16 had renal lesions, 18 had pancreatic lesions and 21 had cerebellar hemangioblastomas. There was no significant difference between survival rates of patients with VHL alone and those with VHL and RCC. However, cancer-specific survival rates were significantly different between patients with both VHL and RCC and patients with sporadic bilateral or multifocal RCC. In our Korean study, the incidence of RCC in patients with VHL disease is 45.8% and the incidence of VHL disease in patients with RCC is 0.73%. Due to the low overall incidence of VHL in Korea, extended multi-institutional studies are needed to establish the true characteristics of VHL disease.
机译:本研究旨在分析韩国患有Hippel-Lindau(VHL)疾病的肾细胞癌(RCC)的临床特征。在1996年1月至2008年7月之间,我们研究所共诊断出1,514例RCC患者,其中24例诊断为VHL病。我们分析了诊断为VHL的24例患者的临床特征。 VHL患者的平均年龄为39.2±12.6岁; VHL和RCC患者的平均年龄为42.5±10.3岁。在24例VHL患者中,有7例视网膜血管瘤,11例RCC,16例肾损害,18例胰腺损害和21例小脑血管母细胞瘤。单纯VHL患者与VHL和RCC患者的生存率之间无显着差异。但是,VHL和RCC的患者与偶发的双侧或多灶RCC的患者之间的癌症特异性生存率显着不同。在我们的韩国研究中,VHL疾病患者中RCC的发生率为45.8%,RCC患者中VHL疾病的发生率为0.73%。由于韩国的VHL总体发病率较低,因此需要进行扩展的多机构研究来确定VHL疾病的真实特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号